-
PROVIDERS
Read more
Browse our latest selection of abstracts, manuscripts, and presentations.
-
LIFE SCIENCES
LIVE WEBINAR
Optimizing research with RWD: How Lens accelerates time to insights in drug discovery.
Register now. -
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
Original Webinar Date:
08/22/2023
The evolving landscape in precision oncology: key research findings from the 2023 ASCO Annual Meeting
Hear from Tempus moderators Dr. Ezra Cohen and Dr. Calvin Chao as they engage in a multi-disciplinary discussion around practice changing approaches to somatic and germline testing with Dr. Ramaswamy Govindan from Siteman Cancer Center and Dr. Cathy Handy Marshall from Johns Hopkins Medicine.
Speakers
Ezra Cohen, MD
Chief Medical Officer of Oncology, Tempus
Calvin Chao, MD
Senior Vice President of Medical Affairs, Tempus
Dr. Ramaswamy Govindan
Professor of Medicine, Washington University in St. Louis, Siteman Cancer Center
Catherine Handy Marshall, MD, MPH
Assistant Professor of Oncology, Johns Hopkins Medicine
Chief Medical Officer of Oncology, Tempus
Calvin Chao, MD
Senior Vice President of Medical Affairs, Tempus
Dr. Ramaswamy Govindan
Professor of Medicine, Washington University in St. Louis, Siteman Cancer Center
Catherine Handy Marshall, MD, MPH
Assistant Professor of Oncology, Johns Hopkins Medicine
We discuss new research data on the potential benefits to tumor/normal matched testing as it relates to incidental germline findings, testing behaviors for NSCLC patients and the most recent findings from the PADA-1 Trial and how it may affect approaches to monitoring resistance mechanisms through liquid biopsy.
-
04/15/2024Identifying patients with Valvular Heart Disease: A partnership between a specialty designated cardiac center and Tempus
Learn how the deployment of Tempus Next, an AI-enabled clinical care pathway solution, at a specialty designated cardiac and heart valve center helped enable guideline directed care for patients with structural heart disease.
Read more -
04/15/2024Closing the biomarker testing gap for early stage NSCLC patients with Tempus Next
Learn how Tempus Next was deployed at TriHealth Cancer and Blood Institute in Cincinnati, Ohio to surface and close gaps in biomarker testing for NSCLC patients.
Read more -
11/15/2023Personalized depression treatment with pharmacogenomic testing
This real-world case shows the impact of using the Tempus nP PGx report to inform treatment in major depressive disorder (MDD).
Read more